Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients

Lilach Soreq; Zvi Israel; Hagai Bergman; Hermona Soreq

doi:10.1016/j.jneuroim.2008.06.019

Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients

Lilach Soreq, Zvi Israel, Hagai Bergman, Hermona Soreq^*

^*Corresponding author for this work

Edmond & Lily Safra Center for Brain Sciences

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Abstract

Laboratory tests for Parkinson's disease (PD) were recently extended to microarray analyses of nucleated blood cells. Here, we report the use of statistical and gene ontology tools to re-examine these microarray data. Distribution plots and PCA mapping enabled removal of several outliers out of the 105 analyzed PD and control samples, which improved the discriminative power for PD blood cells compared to healthy and neurological disease controls. Combined with gene ontology tests, our findings point at neuro-immune signaling-related transcripts as distinctly expressed early in PD progress and call for exploiting microarray tests also for follow-up of PD treatment efficacy.

Original language	English
Pages (from-to)	227-236
Number of pages	10
Journal	Journal of Neuroimmunology
Volume	201-202
Issue number	C
DOIs	https://doi.org/10.1016/j.jneuroim.2008.06.019
State	Published - 15 Sep 2008

Bibliographical note

Funding Information:
We acknowledge the support by the ROSETREES Foundation and the Israeli Ministry of Science and Technology (to H.S.).

Keywords

ANOVA
Affymetrix 3′ microarrays
Blood
Gene ontology
Parkinson's disease

Access to Document

10.1016/j.jneuroim.2008.06.019

Cite this

@article{8cd2d5547b25471a94579677a3747d62,

title = "Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients",

abstract = "Laboratory tests for Parkinson's disease (PD) were recently extended to microarray analyses of nucleated blood cells. Here, we report the use of statistical and gene ontology tools to re-examine these microarray data. Distribution plots and PCA mapping enabled removal of several outliers out of the 105 analyzed PD and control samples, which improved the discriminative power for PD blood cells compared to healthy and neurological disease controls. Combined with gene ontology tests, our findings point at neuro-immune signaling-related transcripts as distinctly expressed early in PD progress and call for exploiting microarray tests also for follow-up of PD treatment efficacy.",

keywords = "ANOVA, Affymetrix 3′ microarrays, Blood, Gene ontology, Parkinson's disease",

author = "Lilach Soreq and Zvi Israel and Hagai Bergman and Hermona Soreq",

note = "Funding Information: We acknowledge the support by the ROSETREES Foundation and the Israeli Ministry of Science and Technology (to H.S.). ",

year = "2008",

month = sep,

day = "15",

doi = "10.1016/j.jneuroim.2008.06.019",

language = "אנגלית",

volume = "201-202",

pages = "227--236",

journal = "Journal of Neuroimmunology",

issn = "0165-5728",

publisher = "Elsevier",

number = "C",

}

TY - JOUR

T1 - Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients

AU - Soreq, Lilach

AU - Israel, Zvi

AU - Bergman, Hagai

AU - Soreq, Hermona

N1 - Funding Information: We acknowledge the support by the ROSETREES Foundation and the Israeli Ministry of Science and Technology (to H.S.).

PY - 2008/9/15

Y1 - 2008/9/15

N2 - Laboratory tests for Parkinson's disease (PD) were recently extended to microarray analyses of nucleated blood cells. Here, we report the use of statistical and gene ontology tools to re-examine these microarray data. Distribution plots and PCA mapping enabled removal of several outliers out of the 105 analyzed PD and control samples, which improved the discriminative power for PD blood cells compared to healthy and neurological disease controls. Combined with gene ontology tests, our findings point at neuro-immune signaling-related transcripts as distinctly expressed early in PD progress and call for exploiting microarray tests also for follow-up of PD treatment efficacy.

AB - Laboratory tests for Parkinson's disease (PD) were recently extended to microarray analyses of nucleated blood cells. Here, we report the use of statistical and gene ontology tools to re-examine these microarray data. Distribution plots and PCA mapping enabled removal of several outliers out of the 105 analyzed PD and control samples, which improved the discriminative power for PD blood cells compared to healthy and neurological disease controls. Combined with gene ontology tests, our findings point at neuro-immune signaling-related transcripts as distinctly expressed early in PD progress and call for exploiting microarray tests also for follow-up of PD treatment efficacy.

KW - ANOVA

KW - Affymetrix 3′ microarrays

KW - Blood

KW - Gene ontology

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=51649090574&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2008.06.019

DO - 10.1016/j.jneuroim.2008.06.019

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 18692253

AN - SCOPUS:51649090574

SN - 0165-5728

VL - 201-202

SP - 227

EP - 236

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

IS - C

ER -

Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this